» Articles » PMID: 9120715

Mutation of the P53 Tumour Suppressor Gene Occurs Preferentially in the Chromophobe Type of Renal Cell Tumour

Overview
Journal J Pathol
Specialty Pathology
Date 1997 Feb 1
PMID 9120715
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Genomic DNA from 30 non-papillary and 20 chromophobe renal cell carcinomas (RCCs), 30 papillary renal cell tumours, and 20 renal oncocytomas was screened for the presence of mutations in exons 5-8 of the p53 tumour suppressor gene by polymerase chain reaction-single strand conformation polymorphism analysis and direct DNA sequencing. Mutations leading to an amino acid change were found only in 6 out 20 chromophobe RCCs. Microsatellite analysis of chromophobe RCCs revealed the loss of one allele at chromosome 17p in 14 out of 18 informative cases. No mutation of the p53 gene was found in five sarcomatous RCCs or in seven tumours of stage IV. This study shows that mutation of the p53 tumour suppressor gene does not correlate with the specific loss of DNA sequences at chromosome 17 in chromophobe RCCs, nor can it be used as a prognostic parameter for RCCs in general.

Citing Articles

Down-Regulation of SREBP via PI3K/AKT/mTOR Pathway Inhibits the Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells.

Zhang B, Wu J, Guo P, Wang Y, Fang Z, Tian J Onco Targets Ther. 2020; 13:8951-8961.

PMID: 32982287 PMC: 7490059. DOI: 10.2147/OTT.S266073.


Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.

Eichenauer T, Shadanpour N, Kluth M, Gobel C, Weidemann S, Fraune C World J Surg Oncol. 2020; 18(1):128.

PMID: 32534597 PMC: 7293794. DOI: 10.1186/s12957-020-01902-y.


Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Yap N, Rajandram R, Ng K, Pailoor J, Fadzli A, Gobe G Biomed Res Int. 2015; 2015:476508.

PMID: 26448938 PMC: 4584050. DOI: 10.1155/2015/476508.


Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.

Durinck S, Stawiski E, Pavia-Jimenez A, Modrusan Z, Kapur P, Jaiswal B Nat Genet. 2014; 47(1):13-21.

PMID: 25401301 PMC: 4489427. DOI: 10.1038/ng.3146.


The circadian clock and the hypoxic response pathway in kidney cancer.

Mazzoccoli G, De Cata A, Piepoli A, Vinciguerra M Tumour Biol. 2013; 35(1):1-7.

PMID: 23943393 DOI: 10.1007/s13277-013-1076-5.